Related Experiment Video

Updated: Jul 16, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

1.6K

Cannabidiol Inhibits the Proliferation and Invasiveness of Prostate Cancer Cells

Eve O'Reilly1,2, Karima Khalifa1,2, Joanne Cosgrave1,2

  • 1UCD School of Biology and Environmental Science, University College Dublin, Dublin D04 C1P1, Ireland.

Journal of Natural Products
|September 13, 2023
PubMed

Insights

Cannabidiol (CBD) shows promise in fighting prostate cancer by inhibiting cell growth and invasion. This study suggests CBD may be a potential future chemotherapeutic agent for prostate cancer treatment.

Area of Science:

  • Oncology
  • Pharmacology

Background:

  • Prostate cancer is a leading cause of cancer death in men.
  • Novel therapeutic strategies are urgently needed to improve patient outcomes.
  • Cannabinoids, derived from cannabis, show preclinical potential against various cancers.

Purpose of the Study:

  • To investigate the antiproliferative and anti-invasive effects of cannabidiol (CBD) on prostate cancer cells in vitro.
  • To explore the molecular mechanisms underlying CBD's action in prostate cancer.

Main Methods:

  • Prostate cancer cell lines were treated with CBD.
  • Cell viability, proliferation, cell cycle protein expression, AKT phosphorylation, and cell invasiveness were assessed.
  • Experiments included the use of cannabinoid receptor antagonists and TRPV1/GPR55 modulators.

Main Results:

  • CBD significantly inhibited prostate cancer cell viability and proliferation.
  • CBD reduced the expression of cell cycle proteins (cyclin D3, CDK2, CDK4, CDK1) and AKT phosphorylation.
  • CBD decreased PC-3 cell invasiveness and increased E-cadherin expression, independent of known cannabinoid targets.

Conclusions:

  • CBD exhibits significant antiproliferative and anti-invasive properties in prostate cancer cells.
  • CBD's mechanism of action appears independent of cannabinoid receptors, TRPV1, and GPR55.
  • CBD demonstrates potential as a novel chemotherapeutic agent for prostate cancer.

More Related Videos

An Orthotopic Murine Model of Human Prostate Cancer Metastasis06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

35.2K
Isolation of Cancer Stem Cells From Human Prostate Cancer Samples07:16

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples

Published on: March 14, 2014

14.2K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
305
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
399
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K